• DE
  • EN
  • IT
  • SBK
  • ES
Logo Regmed Austrian Society for
Regenerative Medicine
  • Home
  • ABOUT US
    • HISTORY AND PHILOSOPHY
    • Mission and Vision
    • ASRM Board
    • Headquarter Team
  • FOR PUBLIC
    • Understanding Regenerative Medicine
      • What is Regenerative Medicine
      • What are stem cells
    • On-going clinical trials
    • Literature
    • Links
  • FOR EXPERTS
    • Become a member
    • Meetings
    • Working groups
    • On-going clinical trials
    • Education programs
      • Workshops
      • Regenerative Medicine training program
    • Career opportunities
    • Scientific cooperation
    • Ethics commission
    • Legislative activities
    • Literature
    • Links
  • JOURNAL
    • About AJRM
    • For Authors
  • REPORTS
    • Regenerative Medizin - Eine Einführung
    • Scientific News
  • DONATE
  • Contact
 

ReNeuron to automate stem cell stroke therapy production for Phase III trial

  • Print
  • Email

ReNeuron

Image Source: www.biopharma-reporter.com 

ReNeuron will automate processing of its stem cell-based stroke therapy ahead of planned Phase III trials using a system acquired from Sartorius Stedim Biotech (SSB) subsidiary, TAP Biosystems.

Read the complete article by Gareth McDonald here: www.biopharma-reporter.com

FaLang translation system by Faboba

Update on diseases and stem cells

Neurological diseases

Clinical trial news SCI

Spinal cord injury

Autoimmune diseases

Crohn's disease

Genetic diseases

Haemopoietic stem cell transplantation for genetic disorders.

Heart diseases

Ischemic cardiovascular disease

Metabolic diseases

Type 1 diabetes

Galerie

Regenerative Medicine

StemCells REM Guardianlv

Scanning Electron Microscope Image of Stem cells
Image Source: guardianlv.com

Newsletter

Follow @regmedaustria

SFbBox by enter-logic-seo.gr

  • Imprint

Copyright ©2015| Austrian Society for Regenerative Medicine

Webdesign & Programmierung by WebWork